Rib Fracture Cryoanalgesia
1 other identifier
observational
5
1 country
1
Brief Summary
Rib fractures lead to poor patient outcomes and even death 3. Data suggests effective pain management is crucial to obtain favorable outcomes 4, 5Current outpatient treatment modalities are limited to oral or topical medications with low efficacy and high risk for opioid dependence. In-patient management with a thoracic epidural TEA is largely considered the gold standard, but the risks of TEA may outweigh the benefits 6 to 8.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 5, 2023
CompletedFirst Submitted
Initial submission to the registry
July 26, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2025
CompletedMarch 23, 2026
June 1, 2025
2 years
July 26, 2023
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain Assessment
Pain assessment using the Numeric Rating Scale for Pain NRS Pain McGill Pain Questionnaire \[MPQ\]), hospital LOS, ICU LOS, ventilator days, pain interference (using the Brief Pain Inventory \[BPI\]), sleep interference (using the Medical Outcomes Sleep Scale \[MOS-Sleep\]), sleep quality (using the Pittsburgh Sleep Quality Index \[PSQI\]), quality of life assessment \[14\], adverse events, re-admissions, and patient satisfaction \[15\].
14 days
Secondary Outcomes (1)
Demographics
30 days
Study Arms (1)
Case Series
Prospective: Case Series The investigators will complete ioveraº system training (i.e., cadaveric demonstration) and work with our local surgical team to develop an effective procedure. The technique will then be refined and considered fully developed with three consecutive successful placements. Data reporting to the sponsor will occur once data for the first five successful interventions and the subsequent 14-day follow-ups are completed. Adverse event reporting to the IRB will occur in accordance with GCP standards. Due to the small sample size and short duration, patients lost to follow-up will be an indication for additional enrollment. No more than 10 total subjects will be enrolled.
Interventions
the use of surgical procedure that produces lesions in peripheral nervous tissue through application of extreme cold
Eligibility Criteria
≥18 years of age Acute pain attributed to rib fracture(s) Able to obtain consent
You may qualify if:
- years of age Acute pain attributed to rib fracture(s) Able to obtain consent
You may not qualify if:
- \<18 years of age Pregnant Incarcerated Confounding injuries or significant pain attributed to secondary injury Patients with any of the following: cryoglobulinemia; paroxysmal cold hemoglobinuria; cold urticarial; Raynaud's disease; open and/or infected wounds at or near the treatment site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Methodist Health Systemlead
- Pacira Pharmaceuticals, Inccollaborator
Study Sites (1)
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Related Publications (15)
Truitt MS, Mooty RC, Amos J, Lorenzo M, Mangram A, Dunn E. Out with the old, in with the new: a novel approach to treating pain associated with rib fractures. World J Surg. 2010 Oct;34(10):2359-62. doi: 10.1007/s00268-010-0651-9.
PMID: 20567973BACKGROUNDTruitt MS, Murry J, Amos J, Lorenzo M, Mangram A, Dunn E, Moore EE. Continuous intercostal nerve blockade for rib fractures: ready for primetime? J Trauma. 2011 Dec;71(6):1548-52; discussion 1552. doi: 10.1097/TA.0b013e31823c96e0.
PMID: 22182865BACKGROUNDIbrahim-Zada I, Bell MT, Campion EM, Pieracci FM, Truitt MS. Delayed presentation of pulmonary hernia following surgical stabilization of severe rib fractures. J Trauma Acute Care Surg. 2016 Aug;81(2):397-9. doi: 10.1097/TA.0000000000001102. No abstract available.
PMID: 27192468BACKGROUNDBeard L, Holt B, Snelson C, Parcha C, Smith FG, Veenith T. Analgesia of Patients with Multiple Rib Fractures in Critical Care: A Survey of Healthcare Professionals in the UK. Indian J Crit Care Med. 2020 Mar;24(3):184-189. doi: 10.5005/jp-journals-10071-23375.
PMID: 32435097BACKGROUNDHo AM, Ho AK, Mizubuti GB, Klar G, Karmakar MK. Regional analgesia for patients with traumatic rib fractures: A narrative review. J Trauma Acute Care Surg. 2020 Jan;88(1):e22-e30. doi: 10.1097/TA.0000000000002524. No abstract available.
PMID: 31688827BACKGROUNDCarrier FM, Turgeon AF, Nicole PC, Trepanier CA, Fergusson DA, Thauvette D, Lessard MR. Effect of epidural analgesia in patients with traumatic rib fractures: a systematic review and meta-analysis of randomized controlled trials. Can J Anaesth. 2009 Mar;56(3):230-42. doi: 10.1007/s12630-009-9052-7. Epub 2009 Feb 11.
PMID: 19247744BACKGROUNDMcKendy KM, Lee LF, Boulva K, Deckelbaum DL, Mulder DS, Razek TS, Grushka JR. Epidural analgesia for traumatic rib fractures is associated with worse outcomes: a matched analysis. J Surg Res. 2017 Jun 15;214:117-123. doi: 10.1016/j.jss.2017.02.057. Epub 2017 Mar 6.
PMID: 28624032BACKGROUNDSheets NW, Davis JW, Dirks RC, Pang AW, Kwok AM, Wolfe MM, Sue LP. Intercostal Nerve Block with Liposomal Bupivacaine vs Epidural Analgesia for the Treatment of Traumatic Rib Fracture. J Am Coll Surg. 2020 Jul;231(1):150-154. doi: 10.1016/j.jamcollsurg.2019.12.044. Epub 2020 Feb 17.
PMID: 32081750BACKGROUNDBritt T, Sturm R, Ricardi R, Labond V. Comparative evaluation of continuous intercostal nerve block or epidural analgesia on the rate of respiratory complications, intensive care unit, and hospital stay following traumatic rib fractures: a retrospective review. Local Reg Anesth. 2015 Oct 27;8:79-84. doi: 10.2147/LRA.S80498. eCollection 2015.
PMID: 26604819BACKGROUNDMohta M, Verma P, Saxena AK, Sethi AK, Tyagi A, Girotra G. Prospective, randomized comparison of continuous thoracic epidural and thoracic paravertebral infusion in patients with unilateral multiple fractured ribs--a pilot study. J Trauma. 2009 Apr;66(4):1096-101. doi: 10.1097/TA.0b013e318166d76d.
PMID: 19359920BACKGROUNDCadaval Gallardo C, Martinez J, Bellia-Munzon G, Nazar M, Sanjurjo D, Toselli L, Martinez-Ferro M. Thoracoscopic cryoanalgesia: A new strategy for postoperative pain control in minimally invasive pectus excavatum repair. Cir Pediatr. 2020 Jan 20;33(1):11-15. English, Spanish.
PMID: 32166917BACKGROUNDDekonenko C, Dorman RM, Duran Y, Juang D, Aguayo P, Fraser JD, Oyetunji TA, Snyder CL, Holcomb GW 3rd, Millspaugh DL, St Peter SD. Postoperative pain control modalities for pectus excavatum repair: A prospective observational study of cryoablation compared to results of a randomized trial of epidural vs patient-controlled analgesia. J Pediatr Surg. 2020 Aug;55(8):1444-1447. doi: 10.1016/j.jpedsurg.2019.09.021. Epub 2019 Oct 26.
PMID: 31699436BACKGROUNDFarley P, Griffin RL, Jansen JO, Bosarge PL. Quantifying Pain Associated With Rib Fractures. J Surg Res. 2020 Feb;246:476-481. doi: 10.1016/j.jss.2019.09.032. Epub 2019 Oct 24.
PMID: 31668607BACKGROUNDBurckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes. 2003 Oct 23;1:60. doi: 10.1186/1477-7525-1-60.
PMID: 14613562BACKGROUNDJenkinson C, Coulter A, Bruster S. The Picker Patient Experience Questionnaire: development and validation using data from in-patient surveys in five countries. Int J Qual Health Care. 2002 Oct;14(5):353-8. doi: 10.1093/intqhc/14.5.353.
PMID: 12389801BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Conner McDaniel, MD
Methodist Heath System
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2023
First Posted
October 23, 2023
Study Start
June 5, 2023
Primary Completion
June 12, 2025
Study Completion
June 12, 2025
Last Updated
March 23, 2026
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- All study-related documents will be retained by the CRI until at least three years after study completion or according to local laws, whichever is longer.
- Access Criteria
- ClinicalTrials.gov
Study data or any protected health information will not be shared with anyone that is not delegated to the study. The PI is committed to disseminate research results in a timely fashion. Sharing of results generated by the data analysis during the course of the project will be through presentation at national scientific meetings and/or publication in open access journals. All information obtained will be source de-identified and presented on a large scale and not traceable to any one particular individual. Data will be shared with the sponsor after all identifiers are removed and a data use agreement fully executed prior to dissemination of any data.